Skip to content

Efficacy of Chlorexidine as Intracanal Medicament in Primary Teeth

Efficacy of 1% Chlorexidine Gel as Intracanal Medicament in Primary Molar Teeth - a Clinical and Microbiological Study

Status
UNKNOWN
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00624572
Enrollment
30
Registered
2008-02-27
Start date
2007-10-31
Completion date
2009-02-28
Last updated
2008-02-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dental Pulp Necrosis

Keywords

primary teeth, chlorexidine, root canal therapy, Pulpectomy

Brief summary

The purpose of this study is to evaluate the action of the chlorexidine as intracanal medicament in the reduction of the levels of bacteria inside root canals of primary molar teeth with pulpal necrosis.

Interventions

DRUGchlorexidine

Chlorexidine gel 1% during 7 days inside root canals

Sponsors

Universidade Federal do Ceara
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
4 Years to 8 Years
Healthy volunteers
No

Inclusion criteria

* Healthy children of both gender; * Without history of reactions or alergical diseases; * With situated age between 04 and 08 years of age * With normal standard of growth and development * Patients with necessity of radical endodontic treatment (pulpectomy) in, at least, two primary molar teeth in different hemi-arches.

Exclusion criteria

* Patients with history of alergical diseases * Patients with allergy to any type of medicine and/or foods * Patients with comprometimento of its general state of health * Healthy patients with risk to develop bacterial endocardite or patients that their general state of health can be aggravated had the transitory bacteremies, as for example children with congenital cardiac illnesses * Patients who are making use of sistemis antibiotics, or that they have made use of sistemic antibiotic in the period of 3 (three) months before the beginning of the endodontic treatment * With periapical x-ray evidencing less than 2/3 of remaining root of the primary tooth to be treated * Patients whose tooth with endodontic necessity to meet in advanced state of root pathological reabsortion * Patients whose legal responsible or parents to refuse to sign the term of free and clarified assent

Countries

Brazil

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026